10/2024

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

10/2024

Oct 28, 2024, 11:50 | Opinion
Gerard Mawhinney: Great work by Oxford Spine Sarcoma Group on Streamlining the Journey of Research Into Clinical Practice
Gerard Mawhinney, Consultant Nurse in Spinal Sarcoma/Surgery at Oxford University Hospital shared on X: "Great…
Oct 28, 2024, 11:44 | Blog
Keeping Abreast with Dr. Miriam Mutebi: Don't let lumps freak you out
Miriam Mutebi, Breast Surgical Oncologist and Assistant Professor in the Department of Surgery at the…
Oct 28, 2024, 11:09 | Insight
SPCC Announces Matti Aapro's Re-election to UICC Board
SPCC (Sharing Progress in Cancer Care) shared a post on LinkedIn: “SPCC is pleased to…
Oct 28, 2024, 11:05 | Career
Silas Deane elected to the Board of Directors at AIM-HI Accelerator Fund
Silas Deane is the Vice President of Courts and Justice at Tyler Technologies. He is…
Oct 28, 2024, 10:54 | Blog
SPCC - Brian Druker reflects on the key milestones of his life and career
SPCC (Sharing Progress in Cancer Care) shared on Linkedin: ''Have you already watched Aleksandra Filipovic’s…
Oct 28, 2024, 10:44 | Blog
Rachael Brown and Scott Glenn bring the experience and passion needed to drive CRI’s next phase of growth and impact
Cancer Research Institute (CRI) shared on Linkedin: ''The Cancer Research Institute is pleased to announce…
Oct 28, 2024, 10:42 | Insight
Myeloma Paper of the Day, October 28th, suggested by Robert Orlowski
Robert Orlowski shared on X: “Myeloma Paper of the Day: Comparison of progression risk of MGUS by…
Oct 28, 2024, 10:36 | Positive
National Academy of Medicine Elects 100 New Members: Part 3
During its annual meeting National Academy of Medicine announced the election of 90 regular members and…
Oct 28, 2024, 10:26 | Insight
Paper Alert! Real-World Survival and Treatment Regimens Across First- to Third-Line Treatment for Advanced Triple-Negative Breast Cancer
Real-World Survival and Treatment Regimens Across First- to Third-Line Treatment for Advanced Triple-Negative Breast Cancer:…
Oct 28, 2024, 10:10 | Blog
Ivana Cattaneo: How we can optimize the link between European led projects and local needs
Ivana Cattaneo, Executive Director Therapeutic Area Advocacy and Precision Medicine, Novartis, shared a post on LinkedIn: "Registration…
All: 2802 Posts: 301 - 310
Special Coverage